J&J’s, Bristol Myers’ Challenges to Medicare Drug Price Negotiations Squashed

Big pharma again came out on the losing end of a major court battle challenging the Biden administration’s Inflation Reduction Act (IRA) drug price negotiations, as a New Jersey federal judge Monday rejected legal challenges from Bristol Myers Squibb and Johnson & Johnson.
Source: Drug Industry Daily